Myomo, Inc. Reports Second Quarter 2017 Results

15Aug

Myomo, Inc. Reports Second Quarter 2017 Results

Portfolio News

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and six months ended June 30, 2017. Read more >>

Share this post

Related Posts

13Jan

Defend against ransomware with these 6 data backup products

Carbonite on list of data backup products. Read more >> read more
29Jun

Paul Gudonis (CEO Of Myomo)

Paul Gudonis (CEO Of Myomo) by The Financial Exchange transcript. Read more >> read more
13Apr

CleanFiber wants to turn millions of tons of cardboard boxes into insulation

...Cardboard would seem like a perfect, paper-based solution to the insulation industry’s short supply, except there’s one problem: Corrugated boxes... read more
02Jun

JDRF Invests in TetraGenetics’ Innovative Approach to Type 1 Diabetes Prevention

A unique scientific approach to preventing, treating and, perhaps one day, curing type 1 diabetes is being coupled with JDRF’s... read more
17Sep

Expectant moms get wellness help from unexpected entrepeneur

Inside a West Greenwich warehouse sit thousands of pretty little boxes, waiting to be shipped to some long-overlooked consumers. “There's been... read more
13Apr

Akston Biosciences CEO to Present at the World Vaccine Congress

Akston Biosciences Corporation, a developer of new classes of biologics, announced that its president and CEO, Todd Zion, Ph.D., has... read more
25Feb

SCBIO caps annual conference in Charleston with $5,000 pitch competition

To close out the SCBIO 2023 conference, three South Carolina early startups in the life sciences industry pitched venture capitalists... read more
18Mar

Carbonite Promotes New Channel Chief With Plans To Integrate Double-Take, Expand Programs

Cloud-based data protection technology developer Carbonite has promoted a relatively new executive to head its channel program. Jon Whitlock, who joined... read more
21Sep

eSight™ Assistive Device for Visually Impaired Available for Demonstrations at AAO

Leading vision enhancement platform, eSight, is holding demonstrations of its current medical device model, eSight 4, at the American Academy... read more
01Dec

Hoth Therapeutics Initiates Confirmatory Study for Lupus Treatment

Hoth Therapeutics, Inc....today announced initiating a confirmatory study, related to their proprietary AEA-loaded Z-pods in the treatment of Cutaneous Lupus... read more